LOGIN  |  REGISTER
Terns Pharmaceuticals

Syra Health to provide Behavioral and Mental Health Screening and Evaluation Services to Law Enforcement Personnel in New Jersey

November 28, 2023 | Last Trade: US$0.44 0.03 6.82

CARMEL, Ind., Nov. 28, 2023 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare company addressing some of healthcare's most significant challenges by providing innovative services and technology solutions, announced today that it has secured a one-year agreement with the County of Camden Psychological Screening and Evaluation Services to provide mental health screening and evaluations to law enforcement personnel in Camden County, New Jersey.

"Law enforcement personnel are critical to community safety, and face unique challenges that impact their mental well-being," said Dr. Deepika Vuppalanchi, CEO, Syra Health. "By providing specialized psychological screening and evaluation services, Syra Health aims to contribute to the overall improvement of behavioral and mental health within this essential population."

Through the agreement, Syra Health will provide pre-employment psychological testing for police officer recruits, intergovernmental transfers, and evaluations for current employees to determine fitness for duty. The need for these services highlights the range of psychological challenges prevalent among police officers. According to the National Alliance on Mental Illness or NAMI, "Compared to the general population, law enforcement report much higher rates of depression, PTSD, burnout, and other anxiety-related mental health conditions.

"As behavioral and mental health continues to grow in importance, opportunities to provide psychological services to other public sector workers are expected to follow," said Sandeep Allam, Executive Chairman and President, Syra Health "We believe this agreement not only validates Syra Health's experience in providing psychological screenings and evaluations, but also opens doors to providing additional solutions. This includes offerings like Syrenity, which provides comprehensive mental health support."

ABOUT SYRA HEALTH CORP. 

Syra Health is a healthcare company addressing some of healthcare's most significant challenges. Syra Health specializes in behavioral and mental health, digital health, and population health. Syra Health's solutions are centered on prevention, improved access, and affordable care.

For more information, please visit www.syrahealth.com.

FORWARD-LOOKING STATEMENTS

Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include, but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty and changes in circumstances. Investors should read the risk factors set forth in our registration statement on Form S-1 and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.

For more information, please contact:

For Media Inquiries:
Christine Drury
Communications and Marketing Director
Syra Health
463-345-5180
This email address is being protected from spambots. You need JavaScript enabled to view it.

For Investor Inquiries:
Ben Shamsian
Vice President
Lytham Partners, LLC
646-829-9701
This email address is being protected from spambots. You need JavaScript enabled to view it. 

Stock Quote

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB